Entry |
|
Symbol |
ATF4, CREB-2, CREB2, TAXREB67, TXREB
|
Name |
(RefSeq) activating transcription factor 4
|
KO |
K04374 | cyclic AMP-dependent transcription factor ATF-4 |
|
Organism |
|
Pathway |
hsa04141 | Protein processing in endoplasmic reticulum |
hsa04261 | Adrenergic signaling in cardiomyocytes |
hsa04925 | Aldosterone synthesis and secretion |
hsa04927 | Cortisol synthesis and secretion |
hsa04928 | Parathyroid hormone synthesis, secretion and action |
hsa04932 | Non-alcoholic fatty liver disease |
hsa04935 | Growth hormone synthesis, secretion and action |
hsa05022 | Pathways of neurodegeneration - multiple diseases |
hsa05163 | Human cytomegalovirus infection |
hsa05166 | Human T-cell leukemia virus 1 infection |
hsa05207 | Chemical carcinogenesis - receptor activation |
|
Network |
|
Element |
N00297 | ACTH-cortisol signaling pathway |
N00298 | CYP11B1-CYP11B2 fusion to ACTH-cortisol signaling pathway |
N00301 | Angiotensin-aldosterone signaling pathway |
N00302 | Mutation-activated CACNA1D/H to angiotensin-aldosterone signaling pathway |
N00303 | Mutation-activated KCNJ5 to angiotensin-aldosterone signaling pathway |
N00304 | Mutation-inactivated ATP1A1 to angiotensin-aldosterone signaling pathway |
N00305 | Mutation-inactivated ATP2B3 to angiotensin-aldosterone signaling pathway |
N00320 | Mutation-activated PRKACA to ACTH-cortisol signaling pathway |
N00321 | Mutation-activated GNAS to ACTH-cortisol signaling pathway |
N00322 | Mutation-inactivated PRKAR1A to ACTH-cortisol signaling pathway |
N00323 | Mutation-inactivated PDE11A/PDE8B to ACTH-cortisol signaling pathway |
N00324 | CRHR-PKA-ACTH signaling pathway |
N00325 | Mutation-inactivated RASD1 to CRHR-PKA-ACTH signaling pathway |
N00326 | Mutation-activated GNAS to CRHR-PKA-ACTH signaling pathway |
N00327 | Mutation-inactivated PRKAR1A to CRHR-PKA-ACTH signaling pathway |
N00410 | DRD1-GNAS-AC-PKA signaling pathway |
N00444 | TNF-p38 signaling pathway |
N00544 | HBV HBx to CREB-mediated transcription |
N00782 | TSH-TG signaling pathway |
N00910 | GHRHR-PKA-GH signaling pathway |
N00981 | Mutation-caused aberrant Htt to CREB-mediated transcription |
N01009 | PERK-ATF4 signaling pathway |
N01010 | Mutation-caused aberrant PSEN1 to PERK-ATF4 signaling pathway |
N01035 | Mutation-caused aberrant SNCA to PERK-ATF4 signaling pathway |
N01149 | Mutation-caused aberrant SOD1 to PERK-ATF4 signaling pathway |
N01198 | Scrapie conformation PrPSc to PERK-ATF4 signaling pathway |
N01204 | PRNP-PI3K-NOX2 signaling pathway |
N01343 | ACH-CHRN-RAS-ERK signaling pathway |
N01351 | E2-ER-RAS-ERK signaling pathway |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09120 Genetic Information Processing
09123 Folding, sorting and degradation
04141 Protein processing in endoplasmic reticulum
468 (ATF4)
09130 Environmental Information Processing
09132 Signal transduction
04668 TNF signaling pathway
468 (ATF4)
04022 cGMP-PKG signaling pathway
468 (ATF4)
04151 PI3K-Akt signaling pathway
468 (ATF4)
09140 Cellular Processes
09141 Transport and catabolism
04137 Mitophagy - animal
468 (ATF4)
09150 Organismal Systems
09152 Endocrine system
04911 Insulin secretion
468 (ATF4)
04922 Glucagon signaling pathway
468 (ATF4)
04915 Estrogen signaling pathway
468 (ATF4)
04926 Relaxin signaling pathway
468 (ATF4)
04935 Growth hormone synthesis, secretion and action
468 (ATF4)
04918 Thyroid hormone synthesis
468 (ATF4)
04928 Parathyroid hormone synthesis, secretion and action
468 (ATF4)
04925 Aldosterone synthesis and secretion
468 (ATF4)
04927 Cortisol synthesis and secretion
468 (ATF4)
09156 Nervous system
04725 Cholinergic synapse
468 (ATF4)
04728 Dopaminergic synapse
468 (ATF4)
04720 Long-term potentiation
468 (ATF4)
04722 Neurotrophin signaling pathway
468 (ATF4)
09149 Aging
04211 Longevity regulating pathway
468 (ATF4)
09160 Human Diseases
09161 Cancer: overview
05207 Chemical carcinogenesis - receptor activation
468 (ATF4)
05203 Viral carcinogenesis
468 (ATF4)
09162 Cancer: specific types
05215 Prostate cancer
468 (ATF4)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
468 (ATF4)
05161 Hepatitis B
468 (ATF4)
05163 Human cytomegalovirus infection
468 (ATF4)
09164 Neurodegenerative disease
05010 Alzheimer disease
468 (ATF4)
05012 Parkinson disease
468 (ATF4)
05014 Amyotrophic lateral sclerosis
468 (ATF4)
05020 Prion disease
468 (ATF4)
05022 Pathways of neurodegeneration - multiple diseases
468 (ATF4)
09165 Substance dependence
05030 Cocaine addiction
468 (ATF4)
05031 Amphetamine addiction
468 (ATF4)
05034 Alcoholism
468 (ATF4)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
468 (ATF4)
09167 Endocrine and metabolic disease
04932 Non-alcoholic fatty liver disease
468 (ATF4)
04934 Cushing syndrome
468 (ATF4)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors [BR:hsa03000]
468 (ATF4)
Transcription factors [BR:hsa03000]
Eukaryotic type
Basic leucine zipper (bZIP)
AP-1(-like) components, CRE-BP/ATF
468 (ATF4)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
LinkDB |
|
Position |
22:39520559..39522686
|
AA seq |
351 aa
MTEMSFLSSEVLVGDLMSPFDQSGLGAEESLGLLDDYLEVAKHFKPHGFSSDKAKAGSSE
WLAVDGLVSPSNNSKEDAFSGTDWMLEKMDLKEFDLDALLGIDDLETMPDDLLTTLDDTC
DLFAPLVQETNKQPPQTVNPIGHLPESLTKPDQVAPFTFLQPLPLSPGVLSSTPDHSFSL
ELGSEVDITEGDRKPDYTAYVAMIPQCIKEEDTPSDNDSGICMSPESYLGSPQHSPSTRG
SPNRSLPSPGVLCGSARPKPYDPPGEKMVAAKVKGEKLDKKLKKMEQNKTAATRYRQKKR
AEQEALTGECKELEKKNEALKERADSLAKEIQYLKDLIEEVRKARGKKRVP |
NT seq |
1056 nt +upstreamnt +downstreamnt
atgaccgaaatgagcttcctgagcagcgaggtgttggtgggggacttgatgtcccccttc
gaccagtcgggtttgggggctgaagaaagcctaggtctcttagatgattacctggaggtg
gccaagcacttcaaacctcatgggttctccagcgacaaggctaaggcgggctcctccgaa
tggctggctgtggatgggttggtcagtccctccaacaacagcaaggaggatgccttctcc
gggacagattggatgttggagaaaatggatttgaaggagttcgacttggatgccctgttg
ggtatagatgacctggaaaccatgccagatgaccttctgaccacgttggatgacacttgt
gatctctttgcccccctagtccaggagactaataagcagcccccccagacggtgaaccca
attggccatctcccagaaagtttaacaaaacccgaccaggttgcccccttcaccttctta
caacctcttcccctttccccaggggtcctgtcctccactccagatcattcctttagttta
gagctgggcagtgaagtggatatcactgaaggagataggaagccagactacactgcttac
gttgccatgatccctcagtgcataaaggaggaagacaccccttcagataatgatagtggc
atctgtatgagcccagagtcctatctggggtctcctcagcacagcccctctaccaggggc
tctccaaataggagcctcccatctccaggtgttctctgtgggtctgcccgtcccaaacct
tacgatcctcctggagagaagatggtagcagcaaaagtaaagggtgagaaactggataag
aagctgaaaaaaatggagcaaaacaagacagcagccactaggtaccgccagaagaagagg
gcggagcaggaggctcttactggtgagtgcaaagagctggaaaagaagaacgaggctcta
aaagagagggcggattccctggccaaggagatccagtacctgaaagatttgatagaagag
gtccgcaaggcaagggggaagaaaagggtcccctag |